These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15923466)

  • 1. Impact of UK policy initiatives on use of medicines to aid smoking cessation.
    West R; DiMarino ME; Gitchell J; McNeill A
    Tob Control; 2005 Jun; 14(3):166-71. PubMed ID: 15923466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.
    Pierce JP; Gilpin EA
    JAMA; 2002 Sep; 288(10):1260-4. PubMed ID: 12215133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the use of aids to cessation in English smokers.
    Kotz D; Fidler J; West R
    Addiction; 2009 Aug; 104(8):1403-10. PubMed ID: 19549267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
    McEwen A; West R; Owen L
    BMC Fam Pract; 2001; 2():6. PubMed ID: 11701091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D; Fidler JA; West R
    Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of nicotine replacement therapy on smoking behavior.
    Cummings KM; Hyland A
    Annu Rev Public Health; 2005; 26():583-99. PubMed ID: 15760302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?
    Gilpin EA; Messer K; Pierce JP
    Nicotine Tob Res; 2006 Oct; 8(5):661-9. PubMed ID: 17008193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General practitioners' views on and referral to NHS smoking cessation services.
    McEwen A; West R; Owen L; Raw M
    Public Health; 2005 Apr; 119(4):262-8. PubMed ID: 15733685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation: integrating recent advances into clinical practice.
    Coleman T
    Thorax; 2001 Jul; 56(7):579-82. PubMed ID: 11413360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.